US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist
  • 23.000
  • +0.650+2.91%
Close Aug 29 16:00 ET
  • 23.000
  • 0.0000.00%
Post 20:02 ET
2.34BMarket Cap-4197P/E (TTM)

Intellia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2023/FY
Stock NameRevenueRatio
Development of genome editing-based therapies36.28M100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States36.28M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Gene Editing
Gene Editing
Intraday+0.87%
ARK Portfolio
ARK Portfolio
Intraday+0.42%